covid 19 News and Research

RSS

Researchers develop innovative profiling methods for SARS-CoV-2 infection

A team of researchers from various institutions in the USA used RNA-sequencing data and other methods to profile unique genes and other characteristics associated with SARS-CoV-2 in New York City (NYC).

17 Mar 2021

How is speech recognition affected by face masks?

News-Medical speaks to Dr. Joe Toscano about his latest research that investigated the impact that face masks have on speech recognition.

17 Mar 2021

COVID-19 has increased stress levels in the U.S pregnant women

COVID-19 has created new problems for pregnant women in the United States, a group that already faced the highest maternal mortality rate in the developed world even before the pandemic.

17 Mar 2021

Abbott Pandemic Defence Coalition aims to identify new viral threats and take quick action

Abbott today announced the formation of the Abbott Pandemic Defence Coalition, a first-of-its-kind global scientific and public health partnership dedicated to the early detection of, and rapid response to, future pandemic threats.

17 Mar 2021

Compromised immunity can allow SARS-CoV-2 to evade the immune system

The vast majority of people infected with SARS-CoV-2 clear the virus, but those with compromised immunity--such as individuals receiving immune-suppressive drugs for autoimmune diseases--can become chronically infected.

17 Mar 2021

Evaluation of Pfizer-BioNTech COVID-19 vaccine among residents of two skilled nursing facilities

The severity of COVID-19 among the residents of long-term care facilities (LTCFs) has been reported to be disproportionately high. Specifically, individuals residing in skilled nursing facilities (SNFs) are found to be the most severely affected, both in terms of morbidity and mortality, and are, thereby, listed for early COVID-19 vaccination. In comparison to the general population, SNF residents are more vulnerable, with a weak immune system.

17 Mar 2021

New study examines the effectiveness of shielding policy for people vulnerable to COVID-19

Shielding vulnerable people has been central to the response to COVID-19, but how well does it work? A Swansea University research project has received funding to examine the evidence, to see what lessons can be learned for the future.

17 Mar 2021

Living with a COVID-19 case brings worse symptoms and stronger antibody response

This study suggests that high virus exposure levels contribute to greater disease severity and stronger antibody responses. The observations from this study are published on the medRxiv preprint server.

17 Mar 2021

People with high BMI may now receive their COVID-19 vaccine in California

Now, California state allows individuals with one of ten comorbidities to get their COVID-19 jabs. This comes after obesity being tagged as COVID-19 vaccine eligibility.

16 Mar 2021

Testing for mRNA-1283, Moderna's next generation COVID-19 vaccine commences

As vaccine efforts against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the coronavirus disease, roll out in various countries, Moderna ups the game by testing its next-generation COVID-19 vaccine.

16 Mar 2021

Salivary IgG to SARS-CoV-2 after mild COVID-19

A team of researchers based in Stockholm, Sweden, has demonstrated that individuals exposed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have antibodies for the disease up to nine months after acquiring the disease, even if they displayed only mild symptoms.

16 Mar 2021

SARS-CoV-2 can spread through cold-chain transport

In light of growing evidence, researchers say that SARS-CoV-2 virus transmission via contaminated surfaces, and in particular, frozen foods and products that are transported while keeping them at low temperatures, should be taken into account when devising prevention strategies.

16 Mar 2021

Novel protein construct prevents lethal COVID-19 in mice

Researchers in the United States have developed a novel protein that prevented lethal disease among mice infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

16 Mar 2021

Study provides insight about development, mental health of underserved ethnically diverse children

A study in the Journal of the American Academy of Child and Adolescent Psychiatry, published by Elsevier, reports on the young adult assessment of the now 20-year longitudinal Boricua Youth Study (BYS), a large cohort that brings much needed insight about development and mental health of children from diverse ethnic background growing up in disadvantaged contexts.

16 Mar 2021

Saliva-based testing as a method for monitoring population immunity to SARS-CoV-2 infection

Researchers in the United States have shown that saliva-based sampling could serve as an accurate and non-invasive alternative to blood sampling for monitoring people’s antibody responses following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or vaccination against the virus.

16 Mar 2021

Study: One in six men with advanced prostate cancer experiences reduced sense of smell and taste

One in six men being treated for advanced prostate cancer experiences a reduced sense of smell and taste, a symptom that could cause increased anxiety among patients because it is also a side effect of COVID-19, according to Tulane researchers.

16 Mar 2021

World TB Day 2021: WHO calls for action to end TB

In just fourteen days, millions around the globe will come together to commemorate World TB Day on 24 March.

16 Mar 2021

Researchers uncover potential new target for anti-COVID-19 therapies

Researchers from Cleveland Clinic's Florida Research and Innovation Center have identified a potential new target for anti-COVID-19 therapies.

16 Mar 2021

URI researchers develop new, saliva-based COVID-19 test

Researchers at the University of Rhode Island have developed a new COVID-19 test that will soon be put into use across its campuses as a screening and surveillance tool for the COVID-19 virus.

16 Mar 2021

SARS-CoV-2 Brazilian variant may potentially escape T cell-mediated host immune responses

A team of scientists from Brazil recently explored the abilities of the UK, South African, and Brazilian variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to evade host CD8+ T cell responses induced by natural infection or vaccination. The findings reveal reduced antigenic coverage for the P.2 Brazilian lineage, indicating its ability to evade SARS-CoV-2-induced T cell responses.

16 Mar 2021

covid 19 News and Research

Researchers develop innovative profiling methods for SARS-CoV-2 infection

How is speech recognition affected by face masks?

COVID-19 has increased stress levels in the U.S pregnant women

Abbott Pandemic Defence Coalition aims to identify new viral threats and take quick action

Compromised immunity can allow SARS-CoV-2 to evade the immune system

Evaluation of Pfizer-BioNTech COVID-19 vaccine among residents of two skilled nursing facilities

New study examines the effectiveness of shielding policy for people vulnerable to COVID-19

Living with a COVID-19 case brings worse symptoms and stronger antibody response

People with high BMI may now receive their COVID-19 vaccine in California

Testing for mRNA-1283, Moderna's next generation COVID-19 vaccine commences

Salivary IgG to SARS-CoV-2 after mild COVID-19

SARS-CoV-2 can spread through cold-chain transport

Novel protein construct prevents lethal COVID-19 in mice

Study provides insight about development, mental health of underserved ethnically diverse children

Saliva-based testing as a method for monitoring population immunity to SARS-CoV-2 infection

Study: One in six men with advanced prostate cancer experiences reduced sense of smell and taste

World TB Day 2021: WHO calls for action to end TB

Researchers uncover potential new target for anti-COVID-19 therapies

URI researchers develop new, saliva-based COVID-19 test

SARS-CoV-2 Brazilian variant may potentially escape T cell-mediated host immune responses

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News